First, if you want more background for this rule, which sits at the intersection of Medicaid Rx reimbursement and drug pricing policy, the above blog post or this 2018 piece I wrote with @nicholas_bagley & Darius Lakdawalla might help. https://t.co/Y6o
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
RT @RESachs: Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley,…
Still reading through the (long!) NPRM, but am excited to see the similarities between the proposal and what @nicholas_bagley, Darius Lakdawalla, and I proposed in 2018 in @JHPPL to ensure the Medicaid best-price rule permits innovative contracting models.
@TopherSpiro Medicaid has a permeable formulary. Meaning, when drugs are approved for covered conditions, they are on the formulary but at "best price" regulations. Azar wants to do away with the best price rule so researchers looked to see if it stifles i
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
RT @RESachs: If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy…
If HHS is only now soliciting comments on questions that are pitched at this level, it might be a long time before any policy changes are proposed. Fortunately, @nicholas_bagley, Darius Lakdawalla, and I wrote a whole article about this question. https://t
RT @RESachs: Still processing the CEA paper, but glad to see the authors took note of the Medicaid best-price work I did with @nicholas_bag…
RT @LorenAdler: Importantly, CEA quotes @RESachs' USC-Brookings Schaeffer Initiative paper on the Medicaid Best-Price Rule. Full paper her…
RT @RESachs: Still processing the CEA paper, but glad to see the authors took note of the Medicaid best-price work I did with @nicholas_bag…
RT @RESachs: Still processing the CEA paper, but glad to see the authors took note of the Medicaid best-price work I did with @nicholas_bag…
Still processing the CEA paper, but glad to see the authors took note of the Medicaid best-price work I did with @nicholas_bagley and Darius Lakdawalla, supported by Brookings. https://t.co/5QPnakNrHw
Importantly, CEA quotes @RESachs' USC-Brookings Schaeffer Initiative paper on the Medicaid Best-Price Rule. Full paper here: https://t.co/rghhqtDuff (w/ @nicholas_bagley & Lakdawalla) https://t.co/T3Pl8RjuCM
@bydavidcrow It doesn't prevent them from doing it. Just means that they'd have to extend the same price (which might read as $0) to Medicaid patients. Do we know how many potential patients are on Medicaid? Have written more here: https://t.co/E9ObXgteYq
@Carolynyjohnson I've argued (with @nicholas_bagley and Darius Lakdawalla) that the best-price rule isn't a monolithic obstacle, but that it does create challenges for some cos in this space. https://t.co/E9ObXgteYq /2
Does #Medicaid best-price rule inhibit move to pay-for-value model in #drugpricing? #pharma #healthcarefinance https://t.co/tNuqSt9g0t https://t.co/OiWtiUTsJp
Innovative drug contracts & Medicaid's best price rule. In @JHPPL https://t.co/qDvOL4r6Ot
Really good stuff for all you drug-contracting geeks. You are all drug-contracting geeks, right? https://t.co/hcLlXnvdFv
RT @SchaefferCenter: Does the Medicaid best-price rule impede adoption of new drug pricing models? https://t.co/n0Yo1IU6AQ
Does the Medicaid best-price rule impede adoption of new drug pricing models? https://t.co/n0Yo1IU6AQ
RT @LorenAdler: Good guide to addressing the areas where the Medicaid Best Price Rule really is an impediment to payment innovation https:/…
Good guide to addressing the areas where the Medicaid Best Price Rule really is an impediment to payment innovation https://t.co/tO1sfNN2GU https://t.co/LH5C2VwelU
RT @LorenAdler: What the Medicaid Best Price Rule actually impedes & what's just noise, from @RESachs, @nicholas_bagley, Lakdawalla https:/…
Interesting insight on impact of The Medicaid "best price" on Pharma; https://t.co/XZNSOHrzyw
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
New analysis: Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule https://t.co/n0Yo1IU6AQ
RT @LorenAdler: What the Medicaid Best Price Rule actually impedes & what's just noise, from @RESachs, @nicholas_bagley, Lakdawalla https:/…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @LorenAdler: What the Medicaid Best Price Rule actually impedes & what's just noise, from @RESachs, @nicholas_bagley, Lakdawalla https:/…
RT @LorenAdler: What the Medicaid Best Price Rule actually impedes & what's just noise, from @RESachs, @nicholas_bagley, Lakdawalla https:/…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
#HealthEconNews Innovative contracting for pharmaceuticals and Medicaid’s best price rule https://t.co/P6WjGnjgEK
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
What the Medicaid Best Price Rule actually impedes & what's just noise, from @RESachs, @nicholas_bagley, Lakdawalla https://t.co/DSRlC0vfIr https://t.co/Bk9Yy3NQZZ
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @onceuponA: I HAVE BEEN WAITING FOR THIS https://t.co/oHgPuWpNb2
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
.@JHPPL article on drugs contracts and medical prices. Timely! https://t.co/3rQqNBz65t
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
RT @nicholas_bagley: Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. htt…
I HAVE BEEN WAITING FOR THIS https://t.co/oHgPuWpNb2
Hot off the presses from @RESachs, Darius Lakdawalla, and me on innovative drug contracts and the best price rule. https://t.co/SjmIED7ZtM